Literature DB >> 14573660

Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii.

Blima Fux1, Cibele V Rodrigues, Ricardo W Portela, Neide M Silva, Chunlei Su, David Sibley, Ricardo W A Vitor, Ricardo T Gazzinelli.   

Abstract

Herein we characterized various genetic markers and the biological behavior of a natural recombinant strain of Toxoplasma gondii (P-Br). From nine genetic markers analyzed, three (B1, ROP1, and SAG1) and three (cS10-A6, GRA6, and SAG3) markers belong to parasites from the type I and type III lineages, respectively. The SAG2 and L363 loci were shown to be type I-III chimera alleles. The cB2l-4 microsatellite marker showed a unique haplotype. The P-Br strain presented low virulence in the acute phase of infection and was cystogenic during the chronic infection. The interleukin 12/gamma interferon axis and inducible nitric oxide synthase were main determinants of resistance during the acute infection with the P-Br strain. As opposed to infection with the type II strain of T. gondii (ME-49), peroral infection with the P-Br strain led only to a light inflammatory infiltrate and no major lesions in the intestine of the C57BL/6 mice. In addition, the BALB/c (resistant to ME-49) and C57BL/6 (susceptible to ME-49) mice were shown, respectively, to be more susceptible and more resistant to cyst formation and toxoplasmic encephalitis when infected with the P-Br strain. Further, the C57BL/KsJ and DBA2/J congenic strains containing major histocompatibility complex (MHC) haplotype "d" were more resistant than the parental strains (C57BL/6 and DBA1/J), when infected with the ME-49 but not with the P-Br strain. Together, our results indicate that resistance to cyst formation and toxoplasmic encephalitis induced during infection with P-Br is not primarily controlled by the MHC haplotype d, as previously reported for type II strains of T. gondii.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573660      PMCID: PMC219541          DOI: 10.1128/IAI.71.11.6392-6401.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene.

Authors:  M E Grigg; J C Boothroyd
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  A follow-up study of Toxoplasma gondii infection in southern Brazil.

Authors:  C Silveira; R Belfort; C Muccioli; M T Abreu; M C Martins; C Victora; R B Nussenblatt; G N Holland
Journal:  Am J Ophthalmol       Date:  2001-03       Impact factor: 5.258

3.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis.

Authors:  M E Grigg; J Ganatra; J C Boothroyd; T P Margolis
Journal:  J Infect Dis       Date:  2001-07-24       Impact factor: 5.226

Review 4.  Reconsidering the pathogenesis of ocular toxoplasmosis.

Authors:  G N Holland
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

5.  Toxoplasma gondii: analysis of different laboratory stocks of the RH strain reveals genetic heterogeneity.

Authors:  D K Howe; L D Sibley
Journal:  Exp Parasitol       Date:  1994-03       Impact factor: 2.011

6.  Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from São Paulo, Brazil: unexpected findings.

Authors:  J P Dubey; D H Graham; C R Blackston; T Lehmann; S M Gennari; A M A Ragozo; S M Nishi; S K Shen; O C H Kwok; D E Hill; P Thulliez
Journal:  Int J Parasitol       Date:  2002-01       Impact factor: 3.981

7.  Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries.

Authors:  M E Grigg; S Bonnefoy; A B Hehl; Y Suzuki; J C Boothroyd
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

8.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice.

Authors:  J M Blackwell; C W Roberts; J Alexander
Journal:  Parasite Immunol       Date:  1993-06       Impact factor: 2.280

10.  Effects of human class I transgenes on Toxoplasma gondii cyst formation.

Authors:  C R Brown; C S David; S J Khare; R McLeod
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

View more
  11 in total

1.  The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii.

Authors:  Elisabeth Kravets; Daniel Degrandi; Stefanie Weidtkamp-Peters; Britta Ries; Carolin Konermann; Suren Felekyan; Julia M Dargazanli; Gerrit J K Praefcke; Claus A M Seidel; Lutz Schmitt; Sander H J Smits; Klaus Pfeffer
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

2.  Genotyping of a Korean isolate of Toxoplasma gondii by multilocus PCR-RFLP and microsatellite analysis.

Authors:  Juan-Hua Quan; Tae Yun Kim; In-Uk Choi; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2008-06       Impact factor: 1.341

3.  Molecular characterization of surface antigen 3 (SAG3) gene of Toxoplasma gondii RH-IVRI strain.

Authors:  Harkirat Singh; B C Saravanan; M Sankar
Journal:  J Parasit Dis       Date:  2012-03-24

4.  Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs.

Authors:  Yanhua Wang; Delin Zhang; Guangxiang Wang; Hong Yin; Meng Wang
Journal:  Parasitol Res       Date:  2013-08-15       Impact factor: 2.289

5.  MOLECULAR CHARACTERIZATION AND SEQUENCE PHYLOGENETIC ANALYSIS OF SURFACE ANTIGEN 3 (SAG3) GENE OF LOCAL INDIAN ISOLATES (CHENNAI AND IZATNAGAR) OF Toxoplasma gondii.

Authors:  Vikrant Sudan; Anup Kumar Tewari; Harkirat Singh
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 May-Jun       Impact factor: 1.846

6.  The quality of methods reporting in parasitology experiments.

Authors:  Oscar Flórez-Vargas; Michael Bramhall; Harry Noyes; Sheena Cruickshank; Robert Stevens; Andy Brass
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

7.  SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.

Authors:  Arlindo G Macêdo; Jair P Cunha; Thyago H S Cardoso; Murilo V Silva; Fernanda M Santiago; João S Silva; Carlos P Pirovani; Deise A O Silva; José R Mineo; Tiago W P Mineo
Journal:  Parasit Vectors       Date:  2013-06-05       Impact factor: 3.876

8.  The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains.

Authors:  Jorge M Freitas; Luciana O Andrade; Simone F Pires; Ricardo Lima; Egler Chiari; Ricardo R Santos; Milena Soares; Carlos R Machado; Gloria R Franco; Sergio D J Pena; Andrea M Macedo
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

9.  Toxoplasma gondii soluble tachyzoite antigen triggers protective mechanisms against fatal intestinal pathology in oral infection of C57BL/6 mice.

Authors:  Luciana Benevides; Cristina R Cardoso; Cristiane M Milanezi; Letícia S Castro-Filice; Paulo V C Barenco; Romulo O Sousa; Rosangela M Rodrigues; José R Mineo; João S Silva; Neide M Silva
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

10.  Heme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice.

Authors:  Ester C B Araujo; Bellisa F Barbosa; Loyane B Coutinho; Paulo V C Barenco; Luciana A Sousa; Cristiane M Milanezi; Giuliano Bonfá; Wander R Pavanelli; João S Silva; Eloisa A V Ferro; Deise A O Silva; Jair P Cunha-Junior; Neide M Silva
Journal:  Vet Res       Date:  2013-10-02       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.